AMANTA HEALTHCARE LIMITED
₹ 120 - ₹ 126
01-Sep-2025 - 03-Sep-2025
₹ 14994.00

/ 119 Shares

AMANTA HEALTHCARE LIMITED

01-Sep-2025 - 03-Sep-2025

₹ 120 - ₹ 126

Price Band

₹ 14994.00

Minimum Investment

119

Bid Lot

10,000,000

Shares

  • Face Value - ₹ 10/- Per Share

  • Listing at BSE, NSE

  • 29,411 Application Required in Retail for 1 Time.

  • Registrar : Link Intime India Private Ltd

IPO Details

Category % Shares/Amount
QIB 50% 5,000,000 Shares RS.63.00 CR
HNI 1 5% 500,000 Shares RS.6.30 CR @ 300 FORM 1X
HNI 2 10% 1,000,000 Shares RS.12.60 CR @ 600 FORM 1X
Retail 35% 3,500,000 Shares RS.44.10 CR @ 29412 FORM 1X

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
29412 FORM 1X 300 FORM 1X 600 FORM 1X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 119 ₹ 14,994
Retail (Upto 2 Lakh) 13 1547 ₹ 194,922
S-HNI (2 Lakh to 10 Lakh) 14 1666 ₹ 209,916
S-HNI (2 Lakh to 10 Lakh) 66 7854 ₹ 989,604
B-HNI (Above 10 Lakh) 67 7973 ₹ 1,004,598

IPO Timeline

  • Open Date

    01-Sep-2025

  • Close Date

    03-Sep-2025

  • Basis of Allotment Date

    04-Sep-2025

  • Initiation of Refunds

    05-Sep-2025

  • Credit Shares to Demat A/c

    05-Sep-2025

  • IPO Listing Date

    08-Sep-2025

Subscription as on
04-Sep-2025 16:49

Category Book Size Subscription No. of Times
QIB 2,000,000 ₹ 25.20 Cr. 57,851,136 ₹ 728.92 Cr. 28.93x
HNI (<10 LAKH) 500,000 ₹ 6.30 Cr. 56,580,216 ₹ 712.91 Cr. 113.16x
HNI2 (>10 LAKH) 1,000,000 ₹ 12.60 Cr. 158,988,879 ₹ 2003.26 Cr. 158.99x
RETAIL 3,500,000 ₹ 44.10 Cr. 122,010,581 ₹ 1537.33 Cr. 34.86x
Total 7,000,000 395,430,812 56.49x
Category Book Size Subscription No. of Times
QIB 2,000,000 ₹ 25.20 Cr. 57,851,136 ₹ 728.92 Cr. 28.93x
HNI (<10 LAKH) 500,000 ₹ 6.30 Cr. 56,580,216 ₹ 712.91 Cr. 113.16x
HNI2 (>10 LAKH) 1,000,000 ₹ 12.60 Cr. 158,988,879 ₹ 2003.26 Cr. 158.99x
RETAIL 3,500,000 ₹ 44.10 Cr. 122,010,581 ₹ 1537.33 Cr. 34.86x
Total 7,000,000 395,430,812 56.49x

*Excluding Anchor

Total No. of Application Approx : ~843295 (28.67 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.

The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.

The company markets products through three business units:

  1. National sales,
  2. International sales and
  3. Product partnering with various foreign and Indian pharmaceutical companies.

The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.

The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.

As of March 31, 2025, the company has a team of 1,718 employees at its formulation and development and quality laboratory.

Read More

Strengths

 

  • Well-established manufacturer of pharmaceutical formulations with a diverse product portfolio and diverse market.
  • Large manufacturing capabilities
  • Wide Domestic and International Marketing Network.

  • Experienced management team supported by a large, diverse and skilled workforce.

Company Promoters

Company Financials

Period Ended 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 381.76 352.12 374.06
Total Income 276.09 281.61 262.70
Profit After Tax 10.50 3.63 -2.11
EBITDA 61.05 58.76 56.31
Net Worth 96.39 66.29 62.88
Reserves and Surplus 67.56 39.46 36.05
Total Borrowing 195.00 205.23 215.66
Amount in ? Crore

Objects of the Issue

The Company Amanta Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No. Objects of the Issue Expected Amount (? in crores)
1 Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat 70.00
2 Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat 30.13
3 General corporate purposes

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to Us.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with Us, in just a few clicks your application is processed. You can bid for any IPO through Us, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment
Message!!

Your file has been successfully uploaded.